Blood test could help doctors choose the right drug for deadly sepsis

NCT ID NCT05824767

Summary

This small, completed pilot study tested whether two substances in the blood (renin and DPP3) can predict which patients with severe septic shock will respond better to a drug called angiotensin II versus standard vasopressor therapy. The goal was to gather information to design a larger future trial, not to prove one treatment is better than the other. Researchers compared the two treatments in 40 adult patients whose blood pressure remained dangerously low despite initial medication.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of New Mexico Health Sciences Center

    Albuquerque, New Mexico, 87106, United States

Conditions

Explore the condition pages connected to this study.